Publication

Midostaurin in patients with indolent systemic mastocytosis: An open-label phase 2 trial

van Anrooij, B., Elberink, J. N. G. O., Span, L. F. R., de Monchy, J. G. R., Rosati, S., Mulder, A. B. & Kluin-Nelemans, J. C., Sep-2018, In : Journal of Allergy and Clinical Immunology. 142, 3, p. 1006-1008.e7 10 p.

Research output: Contribution to journalComment/Letter to the editorAcademicpeer-review

Copy link to clipboard

Documents

  • Midostaurin in patients with indolent systemic mastocytosis

    Final publisher's version, 2 MB, PDF document

DOI

Original languageEnglish
Pages (from-to)1006-1008.e7
Number of pages10
JournalJournal of Allergy and Clinical Immunology
Volume142
Issue number3
Publication statusPublished - Sep-2018

    Keywords

  • ACTIVATED RECEPTOR 2, AIRWAY EPITHELIAL-CELLS, DIET-INDUCED OBESITY, INSULIN-RECEPTOR, RHEUMATOID-ARTHRITIS, ADIPOSE INFLAMMATION, PHOSPHORYLATION, SUBSTRATE-1, EXPRESSION, RELEASE

ID: 75925489